Are placebo-controlled trials still important for obsessive compulsive disorder?

Naomi Fineberg, C. Hawley, T.M. Gale

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Abstract

The use of placebos as reference agents in randomised controlled trials for psychiatric disorders has come under question for ethical reasons. Alternative methods for validating the efficacy of new treatments exist, but may not be as reliable as placebo. In this paper we examine arguments for and against the ongoing use of placebo agents in the development of new treatments for obsessive compulsive disorder in the context of evidence from randomised controlled trials.
Original languageEnglish
Pages (from-to)413-422
JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry
Volume30
Issue number3
DOIs
Publication statusPublished - 2006

Fingerprint

Dive into the research topics of 'Are placebo-controlled trials still important for obsessive compulsive disorder?'. Together they form a unique fingerprint.

Cite this